Clinical Trial

The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study will evaluate the compliance with a daily kava regimen among active smokers who have an intention to quit smoking. This study will also investigate whether kava use can facilitate tobacco cessation, reduce stress, and improve sleep.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2023-04-03; most recent amendment 2026-01-26.
Status change: Not Yet Recruiting → Recruiting 2024-05-02
Trial Details
NCT Number NCT05814055
Lead Sponsor University of Florida
Collaborators: National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH)
Conditions Smoking
Enrollment 76 participants
Start Date 2024-06-06
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-27